share

Aurora A Inhibitor I CAS NO 1158838-45-9


Unit Price:

CAS No.:1158838-45-9

Grade:Pharmacy Grade

Content:99.9%

Brand:Customizable

Packaging:Customizable

Description

Aurora A Inhibitor I CAS NO 1158838-45-9 is a potent and selective small molecule inhibitor of the Aurora A kinase, a key regulator of cell cycle progression and mitosis. This compound is a critical research tool for investigating mitotic spindle assembly, centrosome maturation, and the role of Aurora A in oncogenesis. It is primarily utilized by pharmaceutical R&D teams, academic researchers, and biotechnology companies focused on cancer biology, kinase signaling pathways, and preclinical drug discovery.

Application

  • Biochemical Research: Used as a selective probe to study Aurora A kinase function and its downstream signaling cascades in vitro.
  • Cell Biology Studies: Applied in cell-based assays to investigate the effects of Aurora A inhibition on cell cycle arrest, apoptosis, and aneuploidy.
  • Cancer Research & Target Validation: Serves as a critical tool for validating Aurora A as a therapeutic target in various cancer models, including breast, pancreatic, and ovarian cancers.
  • High-Throughput Screening (HTS): Employed as a reference compound or positive control in screening campaigns to identify novel Aurora A inhibitors.
  • Preclinical Drug Development: Used to establish proof-of-concept and benchmark the efficacy of new drug candidates in oncology research pipelines.
  • Mechanistic Studies: Facilitates research into centrosome amplification, spindle pole integrity, and mitotic checkpoint regulation.

Basic Information

Product Name Aurora A Inhibitor I
CAS No. 1158838-45-9
Molecular Formula C₂₀H₂₀N₆O₂
Molecular Weight 376.41 g/mol
Synonyms MLN8054; Aurora A Kinase Inhibitor I; 4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic Acid; Benzoic acid, 4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy-; Aurora A Inhibitor (MLN8054); MLN 8054; Aurora Kinase A Inhibitor MLN8054
EINECS Contact for details

Quality Control

Our Aurora A Inhibitor I is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure high batch-to-batch consistency and reliability for research. Certificates of Analysis (COA) with detailed chromatograms and spectral data are provided to guarantee compliance with research-grade standards.

Storage

Preserve in a tightly closed container, protected from light. Store at -20°C or below under desiccant. This compound is hygroscopic (moisture-sensitive) and light-sensitive. Allow the vial to warm to room temperature in a desiccator before opening to minimize moisture uptake.

Specification

Item Specification
Appearance Off-white to light yellow solid
Identification (HPLC) Conforms
Identification (MS) Conforms
Purity (HPLC) ≥98.0%
Water Content (KF) ≤1.0%
Solubility Soluble in DMSO, DMF; sparingly soluble in ethanol

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.

Complete Your RFQ

0/ 2000

Why choose US

Trusted Manufacturer

With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.

Rigorous Quality Assurance

Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.

Advanced R&D Expertise

Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.